MBA Advisors
ARKG icon

MBA Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

MBA Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$356K Buy
6,568
+138
+2% +$6.2K 0.12% 117
2026
Q2 		$270K Buy
+6,430
New +$205K 0.09% 128
2021
Q2 		– Sell
-2,268
Closed -$201K – 137
2021
Q1 		$201K Buy
+2,268
New +$225K 0.11% 130

Other funds holding ARKG

Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Florin Court Capital
Florin Court Capital London, United Kingdom $97M AUM 40.08% 1-Year Est. Return
NTV Asset Management
NTV Asset Management Charleston, West Virginia $1.08B AUM 23.94% 1-Year Est. Return
Midwest Financial Partners Investments
Midwest Financial Partners Investments St. Cloud, Minnesota $260M AUM 10.89% 1-Year Est. Return
Canal Insurance Company
Canal Insurance Company Greenville, South Carolina $426M AUM 30.47% 1-Year Est. Return
Gimbal Financial
Gimbal Financial Carmel, Indiana $172M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return

MBA Advisors's ARKG Position: Q3 2026 in Review

MBA Advisors increased its ARK Genomic Revolution ETF (ARKG) stake by 2.1% in Q3 2026, buying an estimated $6.2K and bringing the position to 6,568 shares worth $356K. The position accounts for 0.12% of the portfolio, ranked #117.

MBA Advisors first reported a position in ARKG in Q1 2021 and has held it in 3 quarters since. 191 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

  • MBA Advisors held 6,568 shares of ARK Genomic Revolution ETF worth $356K as of Q3 2026.
  • MBA Advisors bought 138 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $6.2K.
  • ARK Genomic Revolution ETF made up 0.12% of MBA Advisors's portfolio in Q3 2026, its #117 holding.
  • MBA Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 3 quarters since.
  • 191 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on MBA Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.